Transcripts

Ligand Pharmaceuticals (LGND) earnings call transcripts

Earnings call transcripts for Ligand Pharmaceuticals Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as validation of its royalty-aggregation strategy, with Zoma adding scale and duration while keeping underwriting discipline unchanged.

    Aug 06, 2026Confident0.78